(Q69825268)

English

In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis

scientific article published on 01 September 1987

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

title

In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

1 reference

J M Dickinson

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

D A Mitchison

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

publication date

1 September 1987

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

volume

68

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

page(s)

183-193

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

Identifiers

DOI

10.1016/0041-3879(87)90054-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

PubMed publication ID

2834843

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2834843

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2834843%20AND%20SRC:MED&resulttype=core&format=json

(Q69825268)

In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)